Everything seems to change so quickly. How do you stay ahead?
Established in 2024, our mission is simple: to deliver the strategies, innovations and insights of the world's leading CEOs. The pioneers of biotech, pharma, medical devices and healthcare in our time.
Our readership cares about the future of life sciences, and we provide intelligent news for inquiring minds.
Offline, we publish our work in some of the most respected publications in the world, like Fortune, so that you can read our special reports comfortably in living rooms and boardrooms aross North America.
Executive Team
Dr. Adil Ali, Editor-in-Chief. Medicine MBBS, Imperial College London, and Medical Sciences with Endocrinology iBSc, Imperial College London. Previously Doctor, NHS England, Royal Preston Hospital.Lewis Hart, Managing Director. MSc Maths and Computer Science, University of Oxford, BSc Mathematics, King's College London. Previously Editor of 3 annual series of independent sponsored reports for Newsweek.
Editorial Team
Urszula Zacharska, Biotech and Drug Disovery Editor. MSc Experimental and Translational Therapeutics, University of Oxford. BSc, Biomedicine, University of East Anglia. Previously Operations Manager, Recipharm.
